Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy

NCT02166060 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Ivabradine

Sponsor

Medical University of Warsaw